Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide-based Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Injection
1.2.3 Oral
1.2.4 Other
1.3 Market by Application
1.3.1 Global Peptide-based Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide-based Drug Market Perspective (2018-2029)
2.2 Peptide-based Drug Growth Trends by Region
2.2.1 Global Peptide-based Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Peptide-based Drug Historic Market Size by Region (2018-2024)
2.2.3 Peptide-based Drug Forecasted Market Size by Region (2024-2029)
2.3 Peptide-based Drug Market Dynamics
2.3.1 Peptide-based Drug Industry Trends
2.3.2 Peptide-based Drug Market Drivers
2.3.3 Peptide-based Drug Market Challenges
2.3.4 Peptide-based Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide-based Drug Players by Revenue
3.1.1 Global Top Peptide-based Drug Players by Revenue (2018-2024)
3.1.2 Global Peptide-based Drug Revenue Market Share by Players (2018-2024)
3.2 Global Peptide-based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peptide-based Drug Revenue
3.4 Global Peptide-based Drug Market Concentration Ratio
3.4.1 Global Peptide-based Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide-based Drug Revenue in 2022
3.5 Peptide-based Drug Key Players Head office and Area Served
3.6 Key Players Peptide-based Drug Product Solution and Service
3.7 Date of Enter into Peptide-based Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide-based Drug Breakdown Data by Type
4.1 Global Peptide-based Drug Historic Market Size by Type (2018-2024)
4.2 Global Peptide-based Drug Forecasted Market Size by Type (2024-2029)
5 Peptide-based Drug Breakdown Data by Application
5.1 Global Peptide-based Drug Historic Market Size by Application (2018-2024)
5.2 Global Peptide-based Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Peptide-based Drug Market Size (2018-2029)
6.2 North America Peptide-based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Peptide-based Drug Market Size by Country (2018-2024)
6.4 North America Peptide-based Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide-based Drug Market Size (2018-2029)
7.2 Europe Peptide-based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Peptide-based Drug Market Size by Country (2018-2024)
7.4 Europe Peptide-based Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide-based Drug Market Size (2018-2029)
8.2 Asia-Pacific Peptide-based Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Peptide-based Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Peptide-based Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide-based Drug Market Size (2018-2029)
9.2 Latin America Peptide-based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Peptide-based Drug Market Size by Country (2018-2024)
9.4 Latin America Peptide-based Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide-based Drug Market Size (2018-2029)
10.2 Middle East & Africa Peptide-based Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Peptide-based Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Peptide-based Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Peptide-based Drug Introduction
11.1.4 Sanofi Revenue in Peptide-based Drug Business (2018-2024)
11.1.5 Sanofi Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Peptide-based Drug Introduction
11.2.4 Teva Revenue in Peptide-based Drug Business (2018-2024)
11.2.5 Teva Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Detail
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Peptide-based Drug Introduction
11.3.4 Novo Nordisk Revenue in Peptide-based Drug Business (2018-2024)
11.3.5 Novo Nordisk Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Peptide-based Drug Introduction
11.4.4 Takeda Revenue in Peptide-based Drug Business (2018-2024)
11.4.5 Takeda Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Detail
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Peptide-based Drug Introduction
11.5.4 Eli Lilly Revenue in Peptide-based Drug Business (2018-2024)
11.5.5 Eli Lilly Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Peptide-based Drug Introduction
11.6.4 AstraZeneca Revenue in Peptide-based Drug Business (2018-2024)
11.6.5 AstraZeneca Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Peptide-based Drug Introduction
11.7.4 Novartis Revenue in Peptide-based Drug Business (2018-2024)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Peptide-based Drug Introduction
11.8.4 AbbVie Revenue in Peptide-based Drug Business (2018-2024)
11.8.5 AbbVie Recent Development
11.9 Ipsen
11.9.1 Ipsen Company Detail
11.9.2 Ipsen Business Overview
11.9.3 Ipsen Peptide-based Drug Introduction
11.9.4 Ipsen Revenue in Peptide-based Drug Business (2018-2024)
11.9.5 Ipsen Recent Development
11.10 Ferring
11.10.1 Ferring Company Detail
11.10.2 Ferring Business Overview
11.10.3 Ferring Peptide-based Drug Introduction
11.10.4 Ferring Revenue in Peptide-based Drug Business (2018-2024)
11.10.5 Ferring Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Peptide-based Drug Introduction
11.11.4 Merck Revenue in Peptide-based Drug Business (2018-2024)
11.11.5 Merck Recent Development
11.12 The Medicines
11.12.1 The Medicines Company Detail
11.12.2 The Medicines Business Overview
11.12.3 The Medicines Peptide-based Drug Introduction
11.12.4 The Medicines Revenue in Peptide-based Drug Business (2018-2024)
11.12.5 The Medicines Recent Development
11.13 J & J
11.13.1 J & J Company Detail
11.13.2 J & J Business Overview
11.13.3 J & J Peptide-based Drug Introduction
11.13.4 J & J Revenue in Peptide-based Drug Business (2018-2024)
11.13.5 J & J Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Peptide-based Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Injection
Table 3. Key Players of Oral
Table 4. Key Players of Other
Table 5. Global Peptide-based Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Peptide-based Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Peptide-based Drug Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Peptide-based Drug Market Share by Region (2018-2024)
Table 9. Global Peptide-based Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Peptide-based Drug Market Share by Region (2024-2029)
Table 11. Peptide-based Drug Market Trends
Table 12. Peptide-based Drug Market Drivers
Table 13. Peptide-based Drug Market Challenges
Table 14. Peptide-based Drug Market Restraints
Table 15. Global Peptide-based Drug Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Peptide-based Drug Market Share by Players (2018-2024)
Table 17. Global Top Peptide-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-based Drug as of 2022)
Table 18. Ranking of Global Top Peptide-based Drug Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Peptide-based Drug Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Peptide-based Drug Product Solution and Service
Table 22. Date of Enter into Peptide-based Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peptide-based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Peptide-based Drug Revenue Market Share by Type (2018-2024)
Table 26. Global Peptide-based Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Peptide-based Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Peptide-based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Peptide-based Drug Revenue Market Share by Application (2018-2024)
Table 30. Global Peptide-based Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Peptide-based Drug Revenue Market Share by Application (2024-2029)
Table 32. North America Peptide-based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Peptide-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Peptide-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Peptide-based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Peptide-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Peptide-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Peptide-based Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Peptide-based Drug Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Peptide-based Drug Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Peptide-based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Peptide-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Peptide-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Peptide-based Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Peptide-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Peptide-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. Sanofi Company Detail
Table 48. Sanofi Business Overview
Table 49. Sanofi Peptide-based Drug Product
Table 50. Sanofi Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 51. Sanofi Recent Development
Table 52. Teva Company Detail
Table 53. Teva Business Overview
Table 54. Teva Peptide-based Drug Product
Table 55. Teva Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 56. Teva Recent Development
Table 57. Novo Nordisk Company Detail
Table 58. Novo Nordisk Business Overview
Table 59. Novo Nordisk Peptide-based Drug Product
Table 60. Novo Nordisk Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 61. Novo Nordisk Recent Development
Table 62. Takeda Company Detail
Table 63. Takeda Business Overview
Table 64. Takeda Peptide-based Drug Product
Table 65. Takeda Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 66. Takeda Recent Development
Table 67. Eli Lilly Company Detail
Table 68. Eli Lilly Business Overview
Table 69. Eli Lilly Peptide-based Drug Product
Table 70. Eli Lilly Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 71. Eli Lilly Recent Development
Table 72. AstraZeneca Company Detail
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca Peptide-based Drug Product
Table 75. AstraZeneca Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 76. AstraZeneca Recent Development
Table 77. Novartis Company Detail
Table 78. Novartis Business Overview
Table 79. Novartis Peptide-based Drug Product
Table 80. Novartis Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. AbbVie Company Detail
Table 83. AbbVie Business Overview
Table 84. AbbVie Peptide-based Drug Product
Table 85. AbbVie Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 86. AbbVie Recent Development
Table 87. Ipsen Company Detail
Table 88. Ipsen Business Overview
Table 89. Ipsen Peptide-based Drug Product
Table 90. Ipsen Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 91. Ipsen Recent Development
Table 92. Ferring Company Detail
Table 93. Ferring Business Overview
Table 94. Ferring Peptide-based Drug Product
Table 95. Ferring Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 96. Ferring Recent Development
Table 97. Merck Company Detail
Table 98. Merck Business Overview
Table 99. Merck Peptide-based Drug Product
Table 100. Merck Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 101. Merck Recent Development
Table 102. The Medicines Company Detail
Table 103. The Medicines Business Overview
Table 104. The Medicines Peptide-based Drug Product
Table 105. The Medicines Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 106. The Medicines Recent Development
Table 107. J & J Company Detail
Table 108. J & J Business Overview
Table 109. J & J Peptide-based Drug Product
Table 110. J & J Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 111. J & J Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide-based Drug Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Peptide-based Drug Market Share by Type: 2022 VS 2029
Figure 3. Injection Features
Figure 4. Oral Features
Figure 5. Other Features
Figure 6. Global Peptide-based Drug Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Peptide-based Drug Market Share by Application: 2022 VS 2029
Figure 8. Cancer Case Studies
Figure 9. Metabolic Disorders Case Studies
Figure 10. Central Nervous System Case Studies
Figure 11. Other Case Studies
Figure 12. Peptide-based Drug Report Years Considered
Figure 13. Global Peptide-based Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Peptide-based Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Peptide-based Drug Market Share by Region: 2022 VS 2029
Figure 16. Global Peptide-based Drug Market Share by Players in 2022
Figure 17. Global Top Peptide-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-based Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Peptide-based Drug Revenue in 2022
Figure 19. North America Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Peptide-based Drug Market Share by Country (2018-2029)
Figure 21. United States Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Peptide-based Drug Market Share by Country (2018-2029)
Figure 25. Germany Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Peptide-based Drug Market Share by Region (2018-2029)
Figure 33. China Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Peptide-based Drug Market Share by Country (2018-2029)
Figure 41. Mexico Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Peptide-based Drug Market Share by Country (2018-2029)
Figure 45. Turkey Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Sanofi Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 48. Teva Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 49. Novo Nordisk Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 50. Takeda Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 51. Eli Lilly Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 52. AstraZeneca Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 53. Novartis Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 54. AbbVie Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 55. Ipsen Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 56. Ferring Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 57. Merck Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 58. The Medicines Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 59. J & J Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed